GCC Unified Pricing Unit Established, YIACO Medical's Profit Not At Risk

BMI View: We warned throughout 2011 that drug pricing controls were likely to spread within the Gulf Cooperation Council (GCC). The establishment of a joint GCC drug pricing unit vindicates our view that public regulatory bodies in emerging markets will become increasingly involved in reducing the prices of pharmaceuticals, especially in markets where the state is responsible for a large percentage of total healthcare spending. Furthermore, the growth of health insurers as an interest group in pharmaceutical pricing means there is additional commercial pressure to control drug prices in the

To read the full article, please choose one of the following options: